Clinical Trial Update: Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes Patients [NA]

View source ↗

Summary

This clinical trial update notes ongoing recruitment for a study evaluating the efficacy and safety of the Revita DMR Treatment Paradigm 1 and retreatment in ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Revita DMR Treatment Paradigm 1

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Diabetes Mellitus, Type 2 | NA | Status: RECRUITING